For decades, Africa’s pharmaceutical markets have lived in the long shadow of multinational drugmakers. Across Nigeria, Kenya, Ghana, South Africa, and much of Francophone Africa, market leadership, pricing power, hospital procurement preferences, and even perceptions of quality were mainly shaped outside the continent. Indigenous manufacturers existed—but mostly at the margins, constrained by structural rather than […]